RT Journal Article
SR Electronic
T1 Psoriatic Arthritis Quality of Life Instrument: An Assessment of Sensitivity and Response to Change
JF The Journal of Rheumatology
JO J Rheumatol
FD The Journal of Rheumatology
SP 1359
OP 1361
VO 35
IS 7
A1 PAUL J. HEALY
A1 PHILIP S. HELLIWELL
YR 2008
UL http://www.jrheum.org/content/35/7/1359.abstract
AB Objective To assess responsiveness of the Psoriatic Arthritis Quality of Life tool (PsAQoL) and add further data regarding the construct validity of PsAQoL. Methods Twenty-eight patients with PsA underwent clinical assessment over a period of 6 months after change of disease modifying therapy, usually to methotrexate. Measures of outcome included PsAQoL, Health Assessment Questionnaire (HAQ), and assessment of disease activity. Results PsAQoL revealed significant change at 3 and 6 months. Standardized response mean was large at 3 months and small at 6 months. There was strong correlation with other patient-derived measures such as the HAQ and Patient Global at all timepoints. Disease Activity Score-28 and Physician Global showed a relationship with PsAQoL at 3 and 6 months, while a tender joint count relationship was seen only at 6 months. Conclusion The PsAQoL now has responsiveness data and a measure of construct validity to sit alongside previously demonstrated reliability data. Our study has compared the change characteristcs within a group of patients. The next step in the development will require a placebo controlled trial to test discrimination between patients undergoing active treatment or taking placebo.